- ISIN DE000A289VV1
- Country Deutschland
Latest Reports
News Functions
Additional Functions
30 October 2023
HAEMATO AG
Half-yearly financial statements 2023
9 June 2023
HAEMATO AG
Annual financial statements 2022
7 October 2022
HAEMATO AG
Half-yearly financial statements 2022
7 June 2022
HAEMATO AG
Annual financial statements 2021
7 October 2021
HAEMATO AG
Half-yearly financial statements 2021
2 June 2021
HAEMATO AG
Annual financial statements 2020
20 October 2020
HAEMATO AG
Half-yearly financial statements 2020
8 June 2020
HAEMATO AG
Annual financial statements 2019
4 October 2019
HAEMATO AG
Half-yearly financial statements 2019
25 June 2019
HAEMATO AG
Annual financial statements 2018
5 October 2018
HAEMATO AG
Half-yearly financial statements 2018
25 June 2018
HAEMATO AG
Annual financial statements 2017
5 October 2017
HAEMATO AG
Half-yearly financial statements 2017
HAEMATO AG
Annual financial statements 2016
14 September 2016
HAEMATO AG
Halbjahresabschluss 2016
20 June 2016
HAEMATO AG
Jahresabschluss 2015
Latest News
News Functions
Additional Functions
30 November 2023
HAEMATO AG
HAEMATO AG: Termination of listing in the Open Market
16 November 2023
HAEMATO AG
HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
15 November 2023
HAEMATO AG
Termination of the botulinum toxin project
31 August 2023
HAEMATO AG
HAEMATO AG publishes figures for the first half of 2023
31 May 2023
HAEMATO AG
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
16 May 2023
HAEMATO AG
HAEMATO AG: Dividend of EUR 1.20